E Murat Arsava1, Johanna Helenius2, Ross Avery3, Mine H Sorgun4, Gyeong-Moon Kim5, Octavio M Pontes-Neto6, Kwang Yeol Park7, Jonathan Rosand8, Mark Vangel9, Hakan Ay10. 1. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston2Department of Neurology, Hacettepe University, Ankara, Turkey. 2. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston3Department of Neurology, University of Massachusetts Medical School, Worcester4now with Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 3. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston5Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania. 4. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston6Department of Neurology, Faculty of Medicine, Ankara University, Ankara, Turkey. 5. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston7Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 6. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston8Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil. 7. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston9Department of Neurology, Chung-Ang University College of Medicine, Seoul, South Korea. 8. Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston11Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston. 9. Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston. 10. AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston10Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston.
Abstract
Importance: The ability of present-day etiologic stroke classification systems to generate subtypes with discrete stroke characteristics is not known. Objective: To test the hypothesis that etiologic stroke subtyping identifies different disease processes that can be recognized through their different clinical courses. Design, Setting, and Participants: We performed a head-to-head evaluation of the ability of the Causative Classification of Stroke (CCS), Trial of Org 10172 in Acute Stroke Treatment (TOAST), and ASCO (A for atherosclerosis, S for small-vessel disease, C for cardiac source, and O for other cause) classification systems to generate etiologic subtypes with different clinical, imaging, and prognostic characteristics in 1816 patients with ischemic stroke. This study included 2 cohorts recruited at separate periods; the first cohort was recruited between April 2003 and June 2006 and the second between June 2009 and December 2011. Data analysis was performed between June 2014 and May 2016. Main Outcomes and Measures: Separate teams of stroke-trained neurologists performed CCS, TOAST, and ASCO classifications based on information available at the time of hospital discharge. We assessed the association between etiologic subtypes and stroke characteristics by computing receiver operating characteristic curves for binary variables (90-day stroke recurrence and 90-day mortality) and by calculating the ratio of between-category to within-category variability from the analysis of variance for continuous variables (admission National Institutes of Health Stroke Scale score and acute infarct volume). Results: Among the 1816 patients included, the median age was 70 years (interquartile range, 58-80 years) (830 women [46%]). The classification systems differed in their ability to assign stroke etiologies into known subtypes; the size of the undetermined category was 33% by CCS, 53% by TOAST, and 42% by ASCO (P < .001 for all binary comparisons). All systems provided significant discrimination for the validation variables tested. For the primary validation variable (90-day recurrence), the area under the receiver operating characteristic curve was 0.71 (95% CI, 0.66-0.75) for CCS, 0.61 (95% CI, 0.56-0.67) for TOAST, and 0.66 (95% CI, 0.60-0.71) for ASCO (P = .01 for CCS vs ASCO; P < .001 for CCS vs TOAST; P = .13 for ASCO vs TOAST). The classification systems exhibited similar discrimination for 90-day mortality. For admission National Institutes of Health Stroke Scale score and acute infarct volume, CCS generated more distinct subtypes with higher between-category to within-category variability than TOAST and ASCO. Conclusions and Relevance: Our findings suggest that the major etiologic stroke subtypes are distinct categories with different stroke characteristics irrespective of the classification system used to identify them. We further show that CCS generates discrete etiologic categories with more diverse clinical, imaging, and prognostic characteristics than either TOAST or ASCO.
Importance: The ability of present-day etiologic stroke classification systems to generate subtypes with discrete stroke characteristics is not known. Objective: To test the hypothesis that etiologic stroke subtyping identifies different disease processes that can be recognized through their different clinical courses. Design, Setting, and Participants: We performed a head-to-head evaluation of the ability of the Causative Classification of Stroke (CCS), Trial of Org 10172 in Acute Stroke Treatment (TOAST), and ASCO (A for atherosclerosis, S for small-vessel disease, C for cardiac source, and O for other cause) classification systems to generate etiologic subtypes with different clinical, imaging, and prognostic characteristics in 1816 patients with ischemic stroke. This study included 2 cohorts recruited at separate periods; the first cohort was recruited between April 2003 and June 2006 and the second between June 2009 and December 2011. Data analysis was performed between June 2014 and May 2016. Main Outcomes and Measures: Separate teams of stroke-trained neurologists performed CCS, TOAST, and ASCO classifications based on information available at the time of hospital discharge. We assessed the association between etiologic subtypes and stroke characteristics by computing receiver operating characteristic curves for binary variables (90-day stroke recurrence and 90-day mortality) and by calculating the ratio of between-category to within-category variability from the analysis of variance for continuous variables (admission National Institutes of Health Stroke Scale score and acute infarct volume). Results: Among the 1816 patients included, the median age was 70 years (interquartile range, 58-80 years) (830 women [46%]). The classification systems differed in their ability to assign stroke etiologies into known subtypes; the size of the undetermined category was 33% by CCS, 53% by TOAST, and 42% by ASCO (P < .001 for all binary comparisons). All systems provided significant discrimination for the validation variables tested. For the primary validation variable (90-day recurrence), the area under the receiver operating characteristic curve was 0.71 (95% CI, 0.66-0.75) for CCS, 0.61 (95% CI, 0.56-0.67) for TOAST, and 0.66 (95% CI, 0.60-0.71) for ASCO (P = .01 for CCS vs ASCO; P < .001 for CCS vs TOAST; P = .13 for ASCO vs TOAST). The classification systems exhibited similar discrimination for 90-day mortality. For admission National Institutes of Health Stroke Scale score and acute infarct volume, CCS generated more distinct subtypes with higher between-category to within-category variability than TOAST and ASCO. Conclusions and Relevance: Our findings suggest that the major etiologic stroke subtypes are distinct categories with different stroke characteristics irrespective of the classification system used to identify them. We further show that CCS generates discrete etiologic categories with more diverse clinical, imaging, and prognostic characteristics than either TOAST or ASCO.
Authors: E M Arsava; E Ballabio; T Benner; J W Cole; M P Delgado-Martinez; M Dichgans; F Fazekas; K L Furie; K Illoh; K Jood; S Kittner; A G Lindgren; J J Majersik; M J Macleod; W J Meurer; J Montaner; A A Olugbodi; A Pasdar; P Redfors; R Schmidt; P Sharma; A B Singhal; A G Sorensen; C Sudlow; V Thijs; B B Worrall; J Rosand; H Ay Journal: Neurology Date: 2010-10-05 Impact factor: 9.910
Authors: E Murat Arsava; Gyeong-Moon Kim; Jamary Oliveira-Filho; Levent Gungor; Hyun Jin Noh; Morgana de Jesus Lordelo; Ross Avery; Ilko L Maier; Hakan Ay Journal: JAMA Neurol Date: 2016-04 Impact factor: 18.302
Authors: Michael Marnane; Caroline A Duggan; Orla C Sheehan; Aine Merwick; Niamh Hannon; Denis Curtin; Dawn Harris; Emma B Williams; Gillian Horgan; Lorraine Kyne; Patricia M E McCormack; Joseph Duggan; Alan Moore; Gloria Crispino-O'Connell; Peter J Kelly Journal: Stroke Date: 2010-07-01 Impact factor: 7.914
Authors: L B Goldstein; M R Jones; D B Matchar; L J Edwards; J Hoff; V Chilukuri; S B Armstrong; R D Horner Journal: Stroke Date: 2001-05 Impact factor: 7.914
Authors: Matthew I Miller; Agni Orfanoudaki; Michael Cronin; Hanife Saglam; Ivy So Yeon Kim; Oluwafemi Balogun; Maria Tzalidi; Kyriakos Vasilopoulos; Georgia Fanaropoulou; Nina M Fanaropoulou; Jack Kalin; Meghan Hutch; Brenton R Prescott; Benjamin Brush; Emelia J Benjamin; Min Shin; Asim Mian; David M Greer; Stelios M Smirnakis; Charlene J Ong Journal: Neurocrit Care Date: 2022-05-09 Impact factor: 3.532
Authors: Clinton B Wright; Alexander P Auchus; Alan Lerner; Walter T Ambrosius; Hakan Ay; Jeffrey T Bates; Jing Chen; James F Meschia; Suchita Pancholi; Vasilios Papademetriou; Anjay Rastogi; Mary Sweeney; James J Willard; Jerry Yee; Suzanne Oparil Journal: Hypertension Date: 2021-02-15 Impact factor: 10.190
Authors: Mehdi Abbasi; Sean Fitzgerald; Jennifer Ayers-Ringler; Virginia Espina; Claudius Mueller; Sally Rucker; Ramanathan Kadirvel; David Kallmes; Waleed Brinjikji Journal: Cureus Date: 2021-02-22
Authors: Killen H Briones-Claudett; Mónica H Briones-Claudett; Killen H Briones Zamora; Rubén D Nieves Velez; Marlon E Martinez Alvarez; Michelle Grunauer Andrade Journal: Am J Case Rep Date: 2020-06-05